ICU Medical, Inc.
Health
Performance
4.3
Risk
Sell
Buy
Curious about the Scores? Learn more.

ICU Medical, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

08.07.2026
Risk creeping up. Stability not bulletproof anymore.
03.07.2026
Slight bounce. Could be noise – or a comeback brewing.
01.07.2026
Barely upright. Still chaotic, but slowly finding some balance.
20.08.2025
Pulse detected. Still fragile, but stabilizing.
ICUI
ICU Medical, Inc.
158.25
+0.58%
4.3
Sell
Buy
ICU Medical, Inc.

ICU Medical, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does ICU Medical, Inc. do? Business model and key facts

Get the full picture of ICU Medical, Inc.: what it builds, where it operates, and how it makes money.

ICU Medical, Inc. Profile

Sector: Healthcare

Industry: Medical - Instruments & Supplies

Employees (FY): 13000

ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common formulations such as sodium chloride, dextrose, balanced electrolytes, lactated ringer's, mannitol, and sterile water, alongside specialized irrigation solutions like acetic acid and glycine. In medication management, ICU Medical offers sophisticated infusion pumps, including the Plum 360 and LifeCare PCA brands. Its advanced ICU Medical MedNet software enhances medication safety by integrating smart pumps with hospital electronic health records (EHRs), asset tracking, and alarm notification platforms. Accompanying professional services are also provided. For critical care environments, their portfolio features: Hemodynamic Monitoring: Systems like Cogent 2-in-1 and CardioFlo. Cardiac Output & Oximetry: TDQ, OptiQ, and TriOx catheters. Blood Pressure Transducers: Such as Transpac. Blood Sampling Systems: Including the SafeSet closed blood sampling and conservation systems. The company distributes its products to a wide spectrum of healthcare providers, including acute care hospitals, wholesalers, ambulatory clinics, and various alternate site facilities such as outpatient clinics, home healthcare services, and long-term care centers. Established in 1984, ICU Medical maintains its headquarters in San Clemente, California.

shop
Company facts
Vivek Jain
CEO
13000
Employees worldwide
shop
Performance
29.33%
Last 12 months
-20.01%
Last 5 years
shop
Growth
$2.23B
Revenue year
$732,000
Net income
shop
Valuation
$3.94B
Market Cap
4803.70
Price/Earnings Ratio

Stocks related to ICU Medical, Inc.

Selected based on industry alignment and relative market positioning.

MMSI
Merit Medical Systems, Inc.
74.08
-1.46%
4.5
Sell
Buy
Merit Medical Systems, Inc.
STVN
Stevanato Group S.p.A.
18.98
-0.89%
7.2
Sell
Buy
Stevanato Group S.p.A.
BLCO
Bausch + Lomb Corporation
15.97
-0.09%
4.3
Sell
Buy
Bausch + Lomb Corporation
HAE
Haemonetics Corporation
78.00
-0.22%
5.8
Sell
Buy
Haemonetics Corporation
WRBY
Warby Parker Inc.
24.82
+0.92%
8.3
Sell
Buy
Warby Parker Inc.

Events and news impacting ICU Medical, Inc. stock

Earnings, coporate decisions and industry developments that can affect the share price.

ICU Medical, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.